Search Results for: C2i Genomics

Whole genome cancer detection

It wasn’t long ago since the genome was fully decoded. Now, Israel’s C2i Genomics (see here previously) has teamed up with Tel Aviv’s Sourasky (Ichilov) Medical Center take blood test data and perform whole genome minimal residual disease (MRD) testing … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

9 top digital health companies

CB Insights has named nine Israeli-based health-tech startups in its 2021 Top 150 Digital Health Companies transforming healthcare. They include Vocalis, Sweetch, DiA Imaging, B.Well, C2I Genomics, Lumen, Nym Health, Theator and Empathy. https://www.israel21c.org/8-israeli-startups-make-cb-insights-top-150-list/ https://b-well.co.il/  (Hebrew)

Posted in Israel's Medical Achievements | Leave a comment

Blood test to detect recurring cancer

Asaf Zviran co-founded Israel’s C2i Genomics (see here previously). It has developed a blood test that can identify whether a cancer patient will survive after the tumor has been completely removed, or whether further chemotherapy is necessary. https://www.israel21c.org/a-blood-test-that-can-identify-recurrent-cancer/

Posted in Israel's Medical Achievements | Leave a comment

Solving healthcare challenges

The PlayBeyondBio initiative has selected nine Israeli startups for its program for companies developing solutions for future challenges to healthcare systems. C2i Genomics, Nucleai, Itamar medical, Medial Earlysign, iBex, Octopus.health, Imagene, iCardio.ai and Cordio Medical. https://www.calcalistech.com/ctech/articles/0,7340,L-3912456,00.html

Posted in Israel's Medical Achievements | Leave a comment

Funds raised by Israeli startups

BiolineRX raised $4.39 million; Prilenia raised $62.5 million; C2i Genomics raised $12 million; infiniDome raised $1.6 million; Accellix raised $9.5 million; Nucleai raised $6.5 million;

Posted in Economy & Business | Leave a comment

Monitoring cancer post-surgery

At its Israeli R&D center, C2i Genomics has developed a personalized, real-time solution for monitoring recurrence and treatment response for various types of solid cancers. It employs a breakthrough tumor DNA pattern recognition approach for liquid biopsy. https://en.globes.co.il/en/article-cancer-recurrence-monitoring-co-c2i-genomics-raises-12m-1001331769 https://c2i-genomics.com/

Posted in Israel's Medical Achievements | Leave a comment

Exits, takeovers, and mergers – to 14/1/24

Global diagnostics company Veracyte is acquiring Israeli cancer care startup C2i Genomics for $70 – 95 million. US company Delinea has acquired Israeli cybersecurity Authomize for “several tens of million dollars”

Posted in Economy & Business | Leave a comment